Search Within

Heather Jolie Landau

  1. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (268)
  2. Journal Article (121)
  3. Research Letter (12)
  4. Book Section (5)
  5. Review (3)
  6. Conference Paper (1)
  7. Correspondence (1)
  8. Editorial (1)
  9. Guidelines (1)
Groups
  1. Bone Marrow Transplant (413)
  2. Center for Hematologic Malignancies (413)
  3. Department of Medicine (413)
  4. Hematologic Malignancies, Division of (413)
  5. Survivorship Research (413)
  6. Myeloma (238)

More Groups

People
  1. Sergio Giralt (252)
  2. Hani Hassoun (215)
  3. David Chung (199)
  4. Alexander Lesokhin (176)
  5. Gunjan Shah (153)
  6. Neha Korde (136)

More People

Years
  1. 2025 (4)
  2. 2024 (38)
  3. 2023 (48)
  4. 2022 (42)
  5. 2021 (25)
  6. 2020 (34)

More Years

Publications
  1. Blood (140)
  2. Clinical Lymphoma, Myeloma and Leukemia (53)
  3. Biology of Blood and Marrow Transplantation (48)
  4. Journal of Clinical Oncology (24)
  5. Leukemia and Lymphoma (12)
  6. Bone Marrow Transplantation (11)

More Publications

Publishers
  1. American Society of Hematology (149)
  2. Elsevier Inc. (110)
  3. Nature Publishing Group (26)
  4. American Society of Clinical Oncology (25)
  5. Taylor & Francis Group (21)
  6. Ferrata Storti Foundation (8)

More Publishers

Results (413)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT)
    Journal Article

    Dispenzieri, A.; Krishnan, A.; Arendt, B.; Blackwell, B.; Wallace, P. K.; Dasari, S.; Vogl, D. T.; Efebera, Y.; Fei, M.; Geller, N.; more...
    Blood Cancer Journal (2022)

    Fulltext@MSK | Save
  • A randomized phase 3 study of ixazomib–dexamethasone versus physician’s choice in relapsed or refractory AL amyloidosis
    Journal Article

    Dispenzieri, A.; Kastritis, E.; Wechalekar, A. D.; Schönland, S. O.; Kim, K.; Sanchorawala, V.; Landau, H. J.; Kwok, F.; Suzuki, K.; Comenzo, R. L.; more...
    Leukemia (2022)

    Fulltext@MSK | Save
  • Daratumumab versus lenalidomide maintenance therapy for multiple myeloma: A randomized pilot study comparing patient-reported health related quality of life measures
    Meeting Abstract

    Shah, U. A.; Malik, M.; Werner, K.; Burge, M.; Devlin, S. M.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Health-related quality of life and symptoms among patients with relapsed or refractory AL amyloidosis treated with ixazomib-dexamethasone versus physician's choice: Results from a randomized phase 3 trial
    Meeting Abstract

    Sanchorawala, V.; Wechalekar, A. D.; Kim, K.; Schönland, S.; Landau, H. J.; Fiona, K.; Suzuki, K.; Dispenzieri, A.; Merlini, G.; Comenzo, R.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Graded cardiac response criteria for AL amyloidosis: The impact of depth of cardiac response on survival
    Meeting Abstract

    Muchtar, E.; Dispenzieri, A.; Wisniowski, B.; Palladini, G.; Milani, P.; Merlini, G.; Schönland, S.; Veelken, K.; Hegenbart, U.; Kumar, S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Graded renal response criteria for light chain (AL) amyloidosis
    Meeting Abstract

    Muchtar, E.; Wisniowski, B.; Palladini, G.; Milani, P.; Merlini, G.; Schönland, S.; Veelken, K.; Hegenbart, U.; Dispenzieri, A.; Kumar, S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Genomic and immune signatures predict sustained MRD negativity in newly diagnosed multiple myeloma patients treated with daratumumab, carfilzomib, lenalidomide, and dexamethasone (D-KRd)
    Meeting Abstract

    Maura, F.; Boyle, E. M.; Diamond, B.; Blaney, P.; Ghamlouch, H.; Ziccheddu, B.; Wang, Y.; Maclachlan, K. H.; Hoffman, J. E.; Hassoun, H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Belantamab mafodotin in patients with relapsed/refractory multiple myeloma, a real-world experience
    Meeting Abstract

    Hultcrantz, M.; Orozco, J.; Peterson, T. J.; Derkach, A.; Hassoun, H.; Korde, N.; Lu, S. X.; Mailankody, S.; Patel, D.; Shah, U. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Rational targets in systemic AL amyloidosis
    Meeting Abstract

    Bal, S.; Dogan, A.; Hassoun, H.; Mailankody, S.; Giralt, S. A.; Landau, H. J.
    Blood (2021)

    Fulltext@MSK | Save